Literature DB >> 8613231

Obesity hypertension is related more to insulin's fatty acid than glucose action.

B M Egan1, M M Hennes, K T Stepniakowski, I M O'Shaughnessy, A H Kissebah, T L Goodfriend.   

Abstract

Although resistance to insulin-mediated glucose disposal has emerged as a link between abdominal obesity and hypertension, abnormalities of nonesterified fatty acid metabolism may play a greater role. Analyses were performed on existing data from 17 abdominally obese subjects (11 hypertensive, 6 normotensive) to determine whether fatty acid concentration and turnover were related to blood pressure independently of hyperinsulinemia and resistance to insulin-mediated glucose disposal. Glucose utilization, fatty acid concentration, and fatty acid turnover were obtained fasting and during euglycemic hyperinsulinemia at 10 and 40 mU/m/min. Analyses were also performed on another group of 30 subjects with a wide range of risk factors who had blood pressure data as well as glucose and fatty acid measurements during an insulin tolerance test. Fatty acid concentration and turnover were markedly more resistant to suppression by insulin in obese hypertensive than in lean or obese normotensive individuals. In the 17 obese subjects, blood pressure measured at screening, in the laboratory, and over a period of 24 hours correlated significantly with fatty acid concentration and turnover but not with glucose disposal measured during the hyperinsulinemic clamp. These correlations remained significant after fasting insulin, the insulin area under the curve during an oral glucose tolerance test, and glucose disposal during the clamp were controlled for. In the second group of subjects, plasma fatty acids 15 minutes after intravenous insulin also correlated with blood pressure. These correlations remained significant after insulin and an index of sensitivity to insulin-mediated glucose disposal were statistically controlled for. The data indicate that blood pressure is related to the effects of insulin on fatty acid metabolism. The findings raise the possibility that resistance of hormone-sensitive lipase to insulin participates in elevating the blood pressure of abdominally obese hypertensive subjects by increasing fatty acid concentration and turnover.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613231     DOI: 10.1161/01.hyp.27.3.723

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Nonesterified fatty acids in blood pressure control and cardiovascular complications.

Authors:  B M Egan; E L Greene; T L Goodfriend
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects.

Authors:  Aidar R Gosmanov; Dawn D Smiley; Gonzalo Robalino; Joselita Siquiera; Bobby Khan; Ngoc-Anh Le; Riyaz S Patel; Arshed A Quyyumi; Limin Peng; Abbas E Kitabchi; Guillermo E Umpierrez
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-05       Impact factor: 4.310

Review 3.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 4.  Role of hypertension in the metabolic syndrome: who is affected?

Authors:  Gladys Velarde; Bradford C Berk
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

5.  Vascular effects of intravenous intralipid and dextrose infusions in obese subjects.

Authors:  Aidar R Gosmanov; Dawn D Smiley; Limin Peng; Joselita Siquiera; Gonzalo Robalino; Christopher Newton; Guillermo E Umpierrez
Journal:  Metabolism       Date:  2012-04-05       Impact factor: 8.694

6.  Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes.

Authors:  Guillermo E Umpierrez; Dawn Smiley; Gonzalo Robalino; Limin Peng; Abbas E Kitabchi; Bobby Khan; Ahn Le; Arshed Quyyumi; Virgil Brown; Lawrence S Phillips
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

7.  High metabolic substrate load induces mitochondrial dysfunction in rat skeletal muscle microvascular endothelial cells.

Authors:  Camilla Hansen; Karina Olsen; Henriette Pilegaard; Jens Bangsbo; Lasse Gliemann; Ylva Hellsten
Journal:  Physiol Rep       Date:  2021-07

8.  Involvement of peroxisome proliferator-activated receptors in cardiac and vascular remodeling in a novel minipig model of insulin resistance and atherosclerosis induced by consumption of a high-fat/cholesterol diet.

Authors:  Pan Yongming; Cai Zhaowei; Ma Yichao; Zhu Keyan; Chen Liang; Chen Fangming; Xu Xiaoping; Ma Quanxin; Chen Minli
Journal:  Cardiovasc Diabetol       Date:  2015-01-16       Impact factor: 9.951

Review 9.  Analysis of antihypertensive effects of statins.

Authors:  Haralampos J Milionis; Evagelos N Liberopoulos; Moses S Elisaf; Dimitri P Mikhailidis
Journal:  Curr Hypertens Rep       Date:  2007-06       Impact factor: 4.592

10.  PGC-1alpha inhibits oleic acid induced proliferation and migration of rat vascular smooth muscle cells.

Authors:  Yan Zhang; Chang Liu; Lingyun Zhu; Xiaohong Jiang; Xi Chen; Xiaoqiang Qi; Xiangying Liang; Sonia Jin; Peixiang Zhang; Qingguo Li; Dongjin Wang; Xiaofeng Liu; Ke Zeng; Junfeng Zhang; Yang Xiang; Chen-Yu Zhang
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.